BACKGROUND:Xuebijing(XBJ)can alleviate the inflammatory response,improve organ function,and shorten the intensive care unit(ICU)stay in patients with pyogenic liver abscess(PLA)complicated with sepsis,but the molecula...BACKGROUND:Xuebijing(XBJ)can alleviate the inflammatory response,improve organ function,and shorten the intensive care unit(ICU)stay in patients with pyogenic liver abscess(PLA)complicated with sepsis,but the molecular mechanisms have not been elucidated.This study aimed to explore the molecular mechanism of XBJ in treating PLA complicated with sepsis using a network pharmacology approach.METHODS:The active ingredients and targets of XBJ were retrieved from the ETCM database.Potential targets related to PLA and sepsis were retrieved from the GeneCards,PharmGKB,DisGeNet,Online Mendelian Inheritance in Man(OMIM),Therapeutic Targets Database(TTD),and DrugBank databases.The targets of PLA complicated with sepsis were mapped to the targets of XBJ to identify potential treatment targets.Protein-protein interaction networks were analyzed using the STRING database.Potential treatment targets were imported into the Metascape platform for Gene Ontology(GO)functional enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses.Molecular docking was performed to validate the interactions between active ingredients and core targets.RESULTS:XBJ was found to have 54 potential treatment targets for PLA complicated with sepsis.Interleukin-1β(IL-1β),interleukin-6(IL-6),and tumor necrosis factor(TNF)were identifi ed as core targets.KEGG enrichment analysis revealed important pathways,including the interleukin-17(IL-17)signaling pathway,the TNF signaling pathway,the nuclear factor-kappa B(NF-κB)signaling pathway,and the Toll-like receptor(TLR)signaling pathway.Molecular docking experiments indicated stable binding between XBJ active ingredients and core targets.CONCLUSION:XBJ may exert therapeutic eff ects on PLA complicated with sepsis by modulating signaling pathways,such as the IL-17,TNF,NF-κB,and TLR pathways,and targeting IL-1β,IL-6,and TNF.展开更多
Objective:To analyze the therapeutic effect of Xuebijing+antimicrobials in intensive care unit(ICU)patients with severe pneumonia.Methods:60 ICU patients with severe pneumonia from June 2021 to June 2023 were selected...Objective:To analyze the therapeutic effect of Xuebijing+antimicrobials in intensive care unit(ICU)patients with severe pneumonia.Methods:60 ICU patients with severe pneumonia from June 2021 to June 2023 were selected and divided by the random number table method,with 30 cases in each group.The observation group received Xuebijing+antimicrobial treatment,while the control group received only antimicrobial treatment.The differences in rehabilitation indexes,test indexes,and inflammation indexes were compared between the two groups.Results:Mechanical ventilation time,fever reduction time,cough relief time,and hospitalization time of the observation group were significantly shorter than those of the control group(P<0.05);C-reactive protein,procalcitonin,and white blood cell count of the observation group were significantly lower than those of the control group(P<0.05);interleukin-6 and tumor necrosis factor-aαof the observation group were significantly lower than those of the control group(P<0.05).Conclusion:The treatment of severe pneumonia patients in ICU with Xuebijing+antibacterial drugs can reduce inflammation,enhance immune function,shorten the pneumonia recovery time,and reduce the adverse reactions of severe pneumonia.展开更多
目的研究创伤死亡不同血糖水平患者院前创伤评分(revised traum a score,RTC;glasgow com a scale,GCS)、3 d后死亡构成比、感染率和多器官功能不全综合征(mu ltipe organ dysfunction syndrom e,MODS)发生率的变化。方法随机抽查本院1...目的研究创伤死亡不同血糖水平患者院前创伤评分(revised traum a score,RTC;glasgow com a scale,GCS)、3 d后死亡构成比、感染率和多器官功能不全综合征(mu ltipe organ dysfunction syndrom e,MODS)发生率的变化。方法随机抽查本院1999年1月至2005年1月455份住院创伤死亡病历,根据空腹血糖水平及正常参考范围分为创伤死亡正常血糖组57例和创伤死亡高血糖组298例。统计创伤死亡不同血糖水平组RTC、GCS、3 d后死亡构成比、感染率和MODS发生率及的变化,并计算创伤死亡患者血糖与MODS相关定量指标的相关系数。结果①创伤死亡高血糖组RTC为6.31±1.04,GCS为4.23±0.52;创伤死亡正常血糖组RTC为4.43±0.22,GCS为2.21±0.34。创伤死亡高血糖组院前创伤评分明显高于创伤死亡组正常血糖(P<0.01)。②创伤死亡高血糖组3 d后死亡构成比为67.34%,创伤死亡正常血糖组3 d后死亡构成比为17.54%。创伤死亡高血糖组3 d后死亡构成比明显高于创伤死亡正常血糖组(P<0.01)。③创伤死亡高血糖组感染率为83.92%,MODS发生率为71.86%;创伤死亡正常血糖组感染率为21.05%,MODS发生率为10.53%。创伤死亡高血糖组感染率和MODS发生率均明显高于创伤死亡正常血糖组(P<0.01)。④455例创伤死亡患者血糖水平与血ALT、AST、BUN、CRE、PCO2、CK明显正相关(P值均<0.01)。结论创伤死亡高血糖患者院内存活时间长,感染率和MODS发生率高。创伤死亡正常血糖患者伤情重,存活时间短,感染率和MODS发生率低。创伤高血糖患者死亡因素以感染和MODS为主,创伤正常血糖患者死亡因素以非MODS因素(大出血和颅脑直接损伤等)为主。创伤血糖水平升高可作为创伤MODS预警指标,但血糖正常预后也不一定好。展开更多
基金supported by Hunan Province Key Research and Development Program(2020SKC2004).
文摘BACKGROUND:Xuebijing(XBJ)can alleviate the inflammatory response,improve organ function,and shorten the intensive care unit(ICU)stay in patients with pyogenic liver abscess(PLA)complicated with sepsis,but the molecular mechanisms have not been elucidated.This study aimed to explore the molecular mechanism of XBJ in treating PLA complicated with sepsis using a network pharmacology approach.METHODS:The active ingredients and targets of XBJ were retrieved from the ETCM database.Potential targets related to PLA and sepsis were retrieved from the GeneCards,PharmGKB,DisGeNet,Online Mendelian Inheritance in Man(OMIM),Therapeutic Targets Database(TTD),and DrugBank databases.The targets of PLA complicated with sepsis were mapped to the targets of XBJ to identify potential treatment targets.Protein-protein interaction networks were analyzed using the STRING database.Potential treatment targets were imported into the Metascape platform for Gene Ontology(GO)functional enrichment and Kyoto Encyclopedia of Genes and Genomes(KEGG)pathway enrichment analyses.Molecular docking was performed to validate the interactions between active ingredients and core targets.RESULTS:XBJ was found to have 54 potential treatment targets for PLA complicated with sepsis.Interleukin-1β(IL-1β),interleukin-6(IL-6),and tumor necrosis factor(TNF)were identifi ed as core targets.KEGG enrichment analysis revealed important pathways,including the interleukin-17(IL-17)signaling pathway,the TNF signaling pathway,the nuclear factor-kappa B(NF-κB)signaling pathway,and the Toll-like receptor(TLR)signaling pathway.Molecular docking experiments indicated stable binding between XBJ active ingredients and core targets.CONCLUSION:XBJ may exert therapeutic eff ects on PLA complicated with sepsis by modulating signaling pathways,such as the IL-17,TNF,NF-κB,and TLR pathways,and targeting IL-1β,IL-6,and TNF.
文摘Objective:To analyze the therapeutic effect of Xuebijing+antimicrobials in intensive care unit(ICU)patients with severe pneumonia.Methods:60 ICU patients with severe pneumonia from June 2021 to June 2023 were selected and divided by the random number table method,with 30 cases in each group.The observation group received Xuebijing+antimicrobial treatment,while the control group received only antimicrobial treatment.The differences in rehabilitation indexes,test indexes,and inflammation indexes were compared between the two groups.Results:Mechanical ventilation time,fever reduction time,cough relief time,and hospitalization time of the observation group were significantly shorter than those of the control group(P<0.05);C-reactive protein,procalcitonin,and white blood cell count of the observation group were significantly lower than those of the control group(P<0.05);interleukin-6 and tumor necrosis factor-aαof the observation group were significantly lower than those of the control group(P<0.05).Conclusion:The treatment of severe pneumonia patients in ICU with Xuebijing+antibacterial drugs can reduce inflammation,enhance immune function,shorten the pneumonia recovery time,and reduce the adverse reactions of severe pneumonia.
文摘目的研究创伤死亡不同血糖水平患者院前创伤评分(revised traum a score,RTC;glasgow com a scale,GCS)、3 d后死亡构成比、感染率和多器官功能不全综合征(mu ltipe organ dysfunction syndrom e,MODS)发生率的变化。方法随机抽查本院1999年1月至2005年1月455份住院创伤死亡病历,根据空腹血糖水平及正常参考范围分为创伤死亡正常血糖组57例和创伤死亡高血糖组298例。统计创伤死亡不同血糖水平组RTC、GCS、3 d后死亡构成比、感染率和MODS发生率及的变化,并计算创伤死亡患者血糖与MODS相关定量指标的相关系数。结果①创伤死亡高血糖组RTC为6.31±1.04,GCS为4.23±0.52;创伤死亡正常血糖组RTC为4.43±0.22,GCS为2.21±0.34。创伤死亡高血糖组院前创伤评分明显高于创伤死亡组正常血糖(P<0.01)。②创伤死亡高血糖组3 d后死亡构成比为67.34%,创伤死亡正常血糖组3 d后死亡构成比为17.54%。创伤死亡高血糖组3 d后死亡构成比明显高于创伤死亡正常血糖组(P<0.01)。③创伤死亡高血糖组感染率为83.92%,MODS发生率为71.86%;创伤死亡正常血糖组感染率为21.05%,MODS发生率为10.53%。创伤死亡高血糖组感染率和MODS发生率均明显高于创伤死亡正常血糖组(P<0.01)。④455例创伤死亡患者血糖水平与血ALT、AST、BUN、CRE、PCO2、CK明显正相关(P值均<0.01)。结论创伤死亡高血糖患者院内存活时间长,感染率和MODS发生率高。创伤死亡正常血糖患者伤情重,存活时间短,感染率和MODS发生率低。创伤高血糖患者死亡因素以感染和MODS为主,创伤正常血糖患者死亡因素以非MODS因素(大出血和颅脑直接损伤等)为主。创伤血糖水平升高可作为创伤MODS预警指标,但血糖正常预后也不一定好。
